|
|
Wissenschaftliche Publikationen
Originalarbeiten in wissenschaftlichen
Fachzeitschriften:
- Agrawal NS, Miller R Jr, Lal R, Mahanti H, Dixon-Mah YN, DeCandio ML, Vandergrift WA 3rd, Varma AK, Patel SJ, Banik NL, Lindhorst SM, Giglio P, Das A: Current Studies of Immunotherapy on Glioblastoma. J Neurol Neurosurg, 2014; 1 (1).
- Al-Assar O, Demiciorglu F, Lunardi S, Gaspar-Carvalho MM, McKenna WG, Muschel RM, Brunner TB: Contextual regulation of pancreatic cancer stem cell phenotype and radioresistance by pancreatic stellate cells. Radiother Oncol, 2014; 111 (2): 243-251. : http://dx.doi.org/10.1016/j.radonc.2014.03.014
- Bilger A, Bittner MI, Grosu AL, Wiedenmann N, Meyer PT, Firat E, Niedermann G, Weber WA, Milanovic D: FET-PET-based reirradiation and chloroquine in patients with recurrent glioblastoma : First tolerability and feasibility results. Strahlenther Onkol, 2014; 190 (10): 957-961. : http://dx.doi.org/10.1007/s00066-014-0693-2
- Brockmann A, Strittmatter T, May S, Stemmer K, Marx A, Brunner T: Structure-function relationship of thiazolide-induced apoptosis in colorectal tumor cells. Acs Chem Biol, 2014; 9 (7): 1520-1527. : http://dx.doi.org/10.1021/cb500209a
- Bruggmoser G, Saum R, Saum F, Gainey M, Pychlau C, Kapsch RP, Zink K: Correction factors k and k for LiF-TLDs for dosimetry in megavoltage electron and photon beams. Z Med Phys, 2014. : http://dx.doi.org/10.1016/j.zemedi.2014.03.010 (in Druck)
- Brunner TB: [Is D2 and D1 lymphadenectomy for patients with gastric cancer beneficial?]. Strahlenther Onkol, 2014; 190 (6): 592-593.
- Brunner TB, Nestle U, Grosu AL, Partridge M: SBRT in pancreatic cancer: What is the therapeutic window? Radiother Oncol, 2014. : http://dx.doi.org/10.1016/j.radonc.2014.10.015 (in Druck)
- Chang D T, Brunner T, Cheng JC, Liauw S, Meyer J, Wo J: Oncology scan-novel treatment strategies for gastrointestinal cancers. Int J Radiat Oncol, 2014; 89 (4): 699-703. : http://dx.doi.org/10.1016/j.ijrobp.2014.01.048
- Cheney MD, Chen YL, Lim R, Winrich BK, Grosu AL, Trofimov AV, Depauw N, Shih HA, Schwab JH, Hornicek FJ, DeLaney TF: [18F]-Fluoromisonidazole Positron Emission Tomography/Computed Tomography Visualization of Tumor Hypoxia in Patients With Chordoma of the Mobile and Sacrococcygeal Spine. Int J Radiat Oncol, 2014; 90 (5): 1030-1036. : http://dx.doi.org/10.1016/j.ijrobp.2014.08.016
- Doll C, Duncker-Rohr V, Rucker G, Mix M, MacManus M, De Ruysscher D, Vogel W, Eriksen JG, Oyen W, Grosu AL, Weber W, Nestle U: Influence of experience and qualification on PET-based target volume delineation. When there is no expert--ask your colleague. Strahlenther Onkol, 2014; 190 (6): 555-562. : http://dx.doi.org/10.1007/s00066-014-0644-y
- Gaedicke S, Braun F, Prasad S, Machein M, Firat E, Hettich M, Gudihal R, Zhu X, Klingner K, Schuler J, Herold-Mende CC, Grosu AL, Behe M, Weber W, Macke H, Niedermann G: Noninvasive positron emission tomography and fluorescence imaging of CD133+ tumor stem cells. P Natl Acad Sci Usa, 2014; 111 (6): E692-E701. : http://dx.doi.org/10.1073/pnas.1314189111
- Golcher H, Brunner TB, Witzigmann H, Marti L, Bechstein WO, Bruns C, Jungnickel H, Schreiber S, Grabenbauer GG, Meyer T, Merkel S, Fietkau R, Hohenberger W: Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer : Results of the first prospective randomized phase II trial. Strahlenther Onkol, 2014. : http://dx.doi.org/10.1007/s00066-014-0737-7 (in Druck)
- Grosu AL, Weirich G, Wendl C, Prokic V, Kirste S, Geinitz H, Souvatzoglou M, Gschwend JE, Schwaiger M, Molls M, Weber WA, Treiber U, Krause BJ: 11 C-Choline PET/pathology image coregistration in primary localized prostate cancer. Eur J Nucl Med Mol I, 2014; 41: 2242-2248. : http://dx.doi.org/10.1007/s00259-014-2861-0
- Guckenberger M, Andratschke N, Alheit H, Holy R, Moustakis C, Nestle U, Sauer O: Definition of stereotactic body radiotherapy : Principles and practice for the treatment of stage I non-small cell lung cancer. Strahlenther Onkol, 2014; 190 (1): 26-33. : http://dx.doi.org/10.1007/s00066-013-0450-y
- Hoeppner J, Zirlik K, Brunner T, Bronsert P, Kulemann B, Sick O, Marjanovic G, Hopt UT, Makowiec F: Multimodal treatment of locally advanced esophageal adenocarcinoma: which regimen should we choose? Outcome analysis of perioperative chemotherapy versus neoadjuvant chemoradiation in 105 patients. J Surg Oncol, 2014; 109 (3): 287-293. : http://dx.doi.org/10.1002/jso.23498
- Holubyev K, Gainey M, Bratengeier K, Polat B, Flentje M: Generation of prostate IMAT plans adaptable to the inter-fractional changes of patient geometry. Phys Med Biol, 2014; 59 (8): 1947-1962. : http://dx.doi.org/10.1088/0031-9155/59/8/1947
- Jilg CA, Leifert A, Schnell D, Kirste S, Volegova-Neher N, Schlager D, Wieser G, Henne K, Schultze-Seemann W, Grosu AL, Rischke HC: Toxicity and quality of life after choline-PET/CT directed salvage lymph node dissection and adjuvant radiotherapy in nodal recurrent prostate cancer. Radiat Oncol, 2014; 9 (online): 178. : http://dx.doi.org/10.1186/1748-717X-9-178
- Jilg CA, Schultze-Seemann W, Drendel V, Vach W, Wieser G, Krauss T, Jandausch A, Holz S, Henne K, Reske SN, Grosu AL, Weber WA, Rischke HC: Detection of lymph node metastasis in patients with nodal prostate cancer relapse using F/C-choline-PET/CT - influence of size of nodal tumor infiltration and accuracy related to lymph node regions. J Urology, 2014; 192 (1): 103-111. : http://dx.doi.org/10.1016/j.juro.2013.12.054
- Kirste S, Grosu AL: Moderne Strahlentherapie des Prostatakarzinoms Onkologie heute, 2014; 4: 18-20. : http://www.onkologie-heute.info/onkologie-heute/archiv/literaturarchiv/literatur-2014/heft-4-2014/
- Klement RJ: Restricting carbohydrates to fight head and neck cancer-is this realistic? Cancer Biol Med, 2014; 11 (3): 145-161. : http://dx.doi.org/10.7497/j.issn.2095-3941.2014.03.001
- Klement RJ: Mimicking caloric restriction: what about macronutrient manipulation? A response to Meynet and Ricci. Trends Mol Med, 2014; 20 (9): 471-472. : http://dx.doi.org/10.1016/j.molmed.2014.07.001
- Klement RJ, Allgauer M, Appold S, Dieckmann K, Ernst I, Ganswindt U, Holy R, Nestle U, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Andratschke N, Guckenberger M: Support vector machine-based prediction of local tumor control after stereotactic body radiation therapy for early-stage non-small cell lung cancer. Int J Radiat Oncol, 2014; 88 (3): 732-738. : http://dx.doi.org/10.1016/j.ijrobp.2013.11.216
- Klement RJ, Allgauer M, Appold S, Dieckmann K, Ernst I, Ganswindt U, Holy R, Nestle U, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Andratschke N, Guckenberger M: Support vector machine-based prediction of local tumor control after stereotactic body radiation therapy for early-stage non-small cell lung cancer. Int J Radiat Oncol, 2014; 88 (3): 732-738. : http://dx.doi.org/10.1016/j.ijrobp.2013.11.216
- Klement RJ, Champ CE: Calories, carbohydrates, and cancer therapy with radiation: exploiting the five R's through dietary manipulation. Cancer Metast Rev, 2014; 33 (1): 217-229. : http://dx.doi.org/10.1007/s10555-014-9495-3
- Kocher M, Wittig A, Piroth MD, Treuer H, Seegenschmiedt H, Ruge M, Grosu AL, Guckenberger M: Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO Working Group on Stereotactic Radiotherapy. Strahlenther Onkol, 2014; 190 (6): 521-532. : http://dx.doi.org/10.1007/s00066-014-0648-7
- Lagadec C, Vlashi E, Bhuta S, Lai C, Mischel P, Werner M, Henke M, Pajonk F: Tumor cells with low proteasome subunit expression predict overall survival in head and neck cancer patients. Bmc Cancer, 2014; 14: 152-152. : http://dx.doi.org/10.1186/1471-2407-14-152
- Lohaus F, Linge A, Tinhofer I, Budach V, Gkika E, Stuschke M, Balermpas P, Rodel C, Avlar M, Grosu AL, Abdollahi A, Debus J, Bayer C, Belka C, Pigorsch S, Combs SE, Monnich D, Zips D, von Neubeck C, Baretton GB, Lock S, Thames HD, Krause M, Baumann M: HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: Results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). Radiother Oncol, 2014; 113 (3): 317-323. : http://dx.doi.org/10.1016/j.radonc.2014.11.011
- Lunardi S, Jamieson NB, Lim SY, Griffiths KL, Carvalho-Gaspar M, Al-Assar O, Yameen S, Carter RC, McKay CJ, Spoletini G, D'Ugo S, Silva MA, Sansom OJ, Janssen KP, Muschel RJ, Brunner TB: IP-10/CXCL10 induction in human pancreatic cancer stroma influences lymphocytes recruitment and correlates with poor survival. Oncotarget, 2014; 5 (22): 11064-11080.
- Milanovic D, Maier P, Schanne DH, Wenz F, Herskind C: The influence of retinoic Acid and thalidomide on the radiosensitivity of u343 glioblastoma cells. Anticancer Res, 2014; 34 (4): 1885-1891.
- Nieder C, Andratschke N, Angelo K, Haukland E, Grosu AL: Development of a score predicting survival after palliative reirradiation. J Oncol, 2014; 2014: 128240-128240. : http://dx.doi.org/10.1155/2014/128240
- Nieder C, Andratschke NH, Grosu AL: Normal tissue studies in radiation oncology: A systematic review of highly cited articles and citation patterns. Oncol Lett, 2014; 8 (3): 972-976. : http://dx.doi.org/10.3892/ol.2014.2252
- Nieder C, Grosu AL, Gaspar LE: Stereotactic radiosurgery (SRS) for brain metastases: a systematic review. Radiat Oncol, 2014; 9: 155-155. : http://dx.doi.org/10.1186/1748-717X-9-155
- Paidpally V, Chirindel A, Chung CH, Richmon J, Koch W, Quon H, Subramaniam RM: FDG volumetric parameters and survival outcomes after definitive chemoradiotherapy in patients with recurrent head and neck squamous cell carcinoma. Am J Roentgenol, 2014; 203 (2): W139-W145. : http://dx.doi.org/10.2214/AJR.13.11654
- Rischke HC *, Beck T *, Vach W, Wieser G, Grosu AL, Schultze-Seemann W, Meyer PT, Jilg CA: Furosemide diminishes (18)F-fluoroethylcholine uptake in prostate cancer in vivo. Eur J Nucl Med Mol I, 2014; 41 (11): 2074-2082. : http://dx.doi.org/10.1007/s00259-014-2829-0
- Schanne DH, Nestle U, Allgauer M, Andratschke N, Appold S, Dieckmann U, Ernst I, Ganswindt U, Grosu AL, Holy R, Molls M, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Guckenberger M: Stereotactic body radiotherapy for centrally located stage I NSCLC : A multicenter analysis. Strahlenther Onkol, 2014. : http://dx.doi.org/10.1007/s00066-014-0739-5 (in Druck)
- Skripcak T, Belka C, Bosch W, Brink C, Brunner T, Budach V, Buttner D, Debus J, Dekker A, Grau C, Gulliford S, Hurkmans C, Just U, Krause M, Lambin P, Langendijk JA, Lewensohn R, Luhr A, Maingon P, Masucci M, Niyazi M, Poortmans P, Simon M, Schmidberger H, Spezi E, Stuschke M, Valentini V, Verheij M, Whitfield G, Zackrisson B, Zips D, Baumann M: Creating a data exchange strategy for radiotherapy research: Towards federated databases and anonymised public datasets. Radiother Oncol, 2014; 113 (3): 303-309. : http://dx.doi.org/10.1016/j.radonc.2014.10.001
- Sterzing F, Brunner TB, Ernst I, Baus WW, Greve B, Herfarth K, Guckenberger M: Stereotactic body radiotherapy for liver tumors : Principles and practical guidelines of the DEGRO Working Group on Stereotactic Radiotherapy. Strahlenther Onkol, 2014; 190 (10): 872-881. : http://dx.doi.org/10.1007/s00066-014-0714-1
- Wieser G, Mansi R, Grosu AL, Schultze-Seemann W, Dumont-Walter RA, Meyer PT, Maecke HR, Reubi JC, Weber WA: Positron Emission Tomography (PET) Imaging of Prostate Cancer with a Gastrin Releasing Peptide Receptor Antagonist - from Mice to Men. Theranostics, 2014; 4 (4): 412-419. : http://dx.doi.org/10.7150/thno.7324
- Wilson JM, Mukherjee S, Chu KY, Brunner TB, Partridge M, Hawkins M: Challenges in using (1)(8)F-fluorodeoxyglucose-PET-CT to define a biological radiotherapy boost volume in locally advanced pancreatic cancer. Radiat Oncol, 2014; 9: 146-146. : http://dx.doi.org/10.1186/1748-717X-9-146
- Zhu X, Prasad S, Gaedicke S, Hettich M, Firat E, Niedermann G: Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57. Oncotarget, 2014. (in Druck)
|
